Edwards Lifesciences Corporation Accounts Payables 2011-2026 | EW

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables Edwards Lifesciences Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
228 M	197 M	187 M	202 M	204 M	196 M	180 M	134 M	117 M	97.1 M	63.9 M	58.2 M	48.4 M	74.7 M	85 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
228 M	48.4 M	138 M

Quarterly Accounts Payables Edwards Lifesciences Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
165 M	162 M	172 M	197 M	173 M	186 M	212 M	187 M	191 M	193 M	181 M	202 M	155 M	-	159 M	204 M	140 M	145 M	150 M	196 M	196 M	196 M	196 M	180 M	180 M	180 M	180 M	134 M	134 M	134 M	134 M	117 M	117 M	117 M	117 M	97.1 M	97.1 M	97.1 M	97.1 M	63.9 M	63.9 M	63.9 M	63.9 M	58.2 M	58.2 M	58.2 M	58.2 M	48.4 M	48.4 M	-	-	74.7 M	-	-	-	85 M	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
212 M	48.4 M	136 M

Accounts Payables of other stocks in the Medical devices industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Delcath Systems DCTH	2.66 M	$ 9.13	-0.76 %	$ 327 M	USA
Axonics Modulation Technologies AXNX	9.07 M	-	-	$ 3.31 B	USA
Dynatronics Corporation DYNT	3.4 M	-	14.99 %	$ 929 K	USA
Aziyo Biologics AZYO	4.79 M	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	2.76 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	1.21 M	-	3.58 %	$ 2.21 M	USA
Conformis CFMS	4.16 M	-	-	$ 16.4 M	USA
Integra LifeSciences Holdings Corporation IART	82.5 M	$ 9.38	-1.78 %	$ 722 M	USA
Cardiovascular Systems CSII	14.4 M	-	0.15 %	$ 844 M	USA
Second Sight Medical Products EYES	1.03 M	-	-0.97 %	$ 54.4 M	USA
Apollo Endosurgery APEN	7.42 M	-	-	$ 475 M	USA
Inogen INGN	20.3 M	$ 6.5	1.25 %	$ 173 M	USA
IRIDEX Corporation IRIX	4.5 M	$ 1.35	1.89 %	$ 21.8 M	USA
IRadimed Corporation IRMD	1.82 M	$ 98.74	-2.99 %	$ 1.26 B	USA
OrthoPediatrics Corp. KIDS	18.8 M	$ 16.35	0.74 %	$ 384 M	USA
Avinger AVGR	777 K	-	-20.74 %	$ 369 K	USA
LENSAR LNSR	6 M	$ 5.52	-1.08 %	$ 63.6 M	USA
CONMED Corporation CNMD	93.6 M	$ 36.64	-1.19 %	$ 1.14 B	USA
Medtronic PLC MDT	2.45 B	$ 87.67	-0.24 %	$ 113 B	USA
NanoVibronix NAOV	47 K	-	-	$ 1.08 M	USA
Electromed ELMD	2.67 M	$ 24.45	-0.85 %	$ 207 M	USA
Orthofix Medical OFIX	58.4 M	$ 11.79	-1.17 %	$ 467 M	Curacao
Outset Medical OM	554 K	$ 3.52	-0.28 %	$ 53.5 K	USA
Cytosorbents Corporation CTSO	3.34 M	$ 0.6	-10.61 %	$ 32.7 M	USA
Aethlon Medical AEMD	535 K	$ 2.27	-2.16 %	$ 3.54 M	USA
PAVmed PAVM	1.79 M	$ 8.94	-3.87 %	$ 64.7 M	USA
BIOLASE BIOL	6.06 M	-	-13.19 %	$ 166 K	USA
LivaNova PLC LIVN	97.2 M	$ 63.65	0.55 %	$ 3.47 B	Britain
InspireMD NSPR	1.26 M	$ 1.73	-2.26 %	$ 111 M	Israel
Insulet Corporation PODD	75 M	$ 218.11	0.98 %	$ 15.3 B	USA
AdaptHealth Corp. AHCO	352 M	$ 11.41	0.18 %	$ 1.54 B	USA
Quanterix Corporation QTRX	13.6 M	$ 3.9	-1.52 %	$ 166 M	USA
Penumbra PEN	34.7 M	$ 336.42	0.04 %	$ 13.1 B	USA
MiMedx Group MDXG	14.5 M	$ 3.94	-3.9 %	$ 582 M	USA
Invacare Corporation IVC	105 M	-	-	$ 24.7 M	USA
Ra Medical Systems RMED	92 K	-	10.0 %	$ 610 K	USA
Myomo MYO	1.51 M	$ 0.68	-2.2 %	$ 28.5 M	USA
Inspire Medical Systems INSP	36.6 M	$ 50.45	-1.87 %	$ 1.48 B	USA